These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7994377)
1. Prevention of side effects by hemoglobin solutions; the selection of optimal test models, especially concerning thrombogenicity. Bakker JC; Bleeker WK; Den Boer PJ; Biessels PT; Agterberg J; Rigter G; Holthuis JC; Mertens K Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):577-85. PubMed ID: 7994377 [TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of hemoglobin solutions. I. Reactions of vascular endothelial cells to pure and impure hemoglobins. Feola M; Simoni J; Fishman D; Tran R; Canizaro PC Artif Organs; 1989 Jun; 13(3):209-15. PubMed ID: 2669694 [TBL] [Abstract][Full Text] [Related]
3. Reaction of human endothelial cells to bovine hemoglobin solutions and tumor necrosis factor. Simoni J; Simoni G; Lox CD; Feola M Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):777-87. PubMed ID: 7994400 [TBL] [Abstract][Full Text] [Related]
4. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots. Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380 [TBL] [Abstract][Full Text] [Related]
6. Review of modified hemoglobin research at Letterman: attempts to delineate the toxicity of cell-free tetrameric hemoglobin. Hess JR Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):277-89. PubMed ID: 7493049 [TBL] [Abstract][Full Text] [Related]
7. Hemoglobin enhances the binding of bacterial endotoxin to human endothelial cells. Roth RI Thromb Haemost; 1996 Aug; 76(2):258-62. PubMed ID: 8865542 [TBL] [Abstract][Full Text] [Related]
8. Effects of endogenous ascorbate on oxidation, oxygenation, and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig. Buehler PW; D'Agnillo F; Hoffman V; Alayash AI J Pharmacol Exp Ther; 2007 Oct; 323(1):49-60. PubMed ID: 17622572 [TBL] [Abstract][Full Text] [Related]
10. Production of modified crosslinked cell-free hemoglobin for human use: the role of quantitative determination of endotoxin contamination. Roth RI; Levin J; Chapman KW; Schmeizl M; Rickles FR Transfusion; 1993; 33(11):919-24. PubMed ID: 8259598 [TBL] [Abstract][Full Text] [Related]
12. Expression of adhesion molecules and von Willebrand factor in human coronary artery endothelial cells incubated with differently modified hemoglobin solutions. Simoni J; Simoni G; Lox CD; Prien SD; Tran R; Shires GT Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):211-25. PubMed ID: 9083640 [TBL] [Abstract][Full Text] [Related]
13. Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants. Simoni J; Simoni G; Lox CD; McGunegle DE; Feola M Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):525-34. PubMed ID: 7994374 [TBL] [Abstract][Full Text] [Related]
14. Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems. Buehler PW; Alayash AI Transfusion; 2004 Oct; 44(10):1516-30. PubMed ID: 15383027 [TBL] [Abstract][Full Text] [Related]
15. Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II--Pharmacotoxicological evaluation. Menu P; Faivre B; Labrude P; Riffard P; Grandgeorge M; Vigneron C Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):543-9. PubMed ID: 7527720 [TBL] [Abstract][Full Text] [Related]
16. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563 [TBL] [Abstract][Full Text] [Related]
17. The role of the pulmonary circulation in the regulation of coagulation and fibrinolysis in relation to major surgery. Dahl OE J Cardiothorac Vasc Anesth; 1997 May; 11(3):322-8. PubMed ID: 9161901 [TBL] [Abstract][Full Text] [Related]
18. Generation of free oxygen radicals and the toxicity of hemoglobin solutions. Simoni J; Feola M; Canizaro PC Biomater Artif Cells Artif Organs; 1990; 18(2):189-202. PubMed ID: 2369646 [TBL] [Abstract][Full Text] [Related]
19. Modified hemoglobin solution, with desired pharmacological properties, does not activate nuclear transcription factor NF-kappa B in human vascular endothelial cells. Simoni J; Simoni G; Lox CD; Prien SD; Shires GT Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):193-210. PubMed ID: 9083639 [TBL] [Abstract][Full Text] [Related]
20. Biological response of human aortic endothelial cells exposed to acellular hemoglobin solutions developed as potential blood substitutes. Toussaint-Hacquard M; Devaux Y; Longrois D; Faivre-Fiorina B; Muller S; Stoltz JF; Vigneron C; Menu P Life Sci; 2003 Jan; 72(10):1143-57. PubMed ID: 12505545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]